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A b s t r a c t 
 
Solid, nanoporous silica-based spherical mesoporous MCM-41 and KIL-2 with interparticle 
mesoporosity as well as nanosized zeolite BEA materials differing in morphology and pore 
size distribution, were used as carriers for the preparation of resveratrol-loaded delivery 
systems. Two preparation methods have been applied: (i) loading by mixing of resveratrol and 
mesoporous carrier in solid state and (ii) deposition in ethanol solution. The parent and the 
resveratrol loaded carriers were characterized by XRD, TEM, N2 physisorption, thermal 
analysis, and FT-IR spectroscopy. The influence of the support structure on the adsorption 
capacity and the release kinetics of this poorly soluble compound were investigated. Our 
results indicated that the chosen nanoporous silica supports are suitable for stabilization of 
trans-resveratrol and reveal controlled release and ability to protect the supported compound 
against degradation regardless of loading method. The solid-state dry mixing appears very 
effective for preparation of drug formulations composed of poorly soluble compound. 
 
 
1.  Introduction 
 
Mesoporous silicas and zeolites are promising materials for various aspects of biomedical 
applications. The preparation of meso – and microporous silica delivery systems for drugs and 
bioactive molecules is based on the advantages of these materials– tunable pore size, 
controlled particle size and morphology, dual-functional surface (external and internal) and 
chemical composition  [1–3]. Thus, their application as drug carriers can solve some problems 
associated with low stability and poor bioavailability of the active molecules. 
Resveratrol (trans-3,4,5-trihydroxystilbene), (R) is a potential antioxidant with strong anti-
inflammatory and antiproliferative properties, which can be found in grapes, nuts, fruits and 
red wine ( Scheme 1). It is extremely photosensitive compound with low chemical stability, 
which limits its beneficial therapeutic effects  [4]. Thus, loading of resveratrol in nanoporous 
silica systems can stabilize and protect it from degradation. In addition, the increased specific 
surface area of mesoporous silica particles could eventually improve its bioavailability. 
It is well known that preparation method of drug formulations can influence the solubility of 
active substance, its loading degree and release profile. Most investigated methods regarding 
improvement of water solubility are surfactant solubilisation, complexation and micronisation 
of drugs. A more efficient method to increase drug solubility in water and dissolution velocity 
was developed at the beginning of the nineties by drug amorphization. A review of some 
nanotechnologies, commercialized to help deliver poorly water-soluble drugs is made by 
Kharb et al.  [5]. Production of nanocrystalline particles has been attained by different milling 
techniques leading to amorphization and hence to drug solubility increase. Wet-milling 
technique [6], physical mixing (paste) [7], ball milling and high pressure homogenization in 
water [8,9], spray-drying of the drug dissolved in its amorphous/nanocrystalline state on the 
support [10] and even melt method [11], consisting in heating of a mixture of the drug 
(itraconazole or ibuprofen) with SBA-15 support have been developed for drug 
amorphization. 
In this study a procedure for dry physical mixing of resveratrol and two types of supports has 
been applied. Solid nanoporous silica-based materials differing in morphology, topology and 
pore size distribution, such as mesoporous pure silica (spherical MCM-41 and KIL-2) and 
nanosized silica-alumina zeolite BEA have been used as carriers. Vibrational ball mill mixer 
was applied for simultaneous amorphization and loading of the poorly water-soluble drug. To 
the best of our knowledge, such type of mechanical deposition of resveratrol on the chosen 
silica nanomaterials has not been reported. This solid-state procedure for encapsulation has 
two important advantages. Dry mixing ensures partial amorphization of resveratrol 
crystallites, expected to increase its water solubility. The other priority is that the whole 
amount of added drug substance should remain on the carrier without any loss at preparation. 
The physico-chemical characteristics, the adsorption capacity and the drug-release kinetics of 
the formulations prepared by the solid-state method have been compared to their analogues 
obtained by the conventional method of encapsulation in solution. 
 
 
 
 
 
Scheme 1. Cis- and trans-resveratrol 
2.  Experimental 
 
2.1.  Synthesis of spherical MCM-41 silica material 
 
MCM-41 with 100 nm particle size was prepared according to the procedure of Huh et al.  
[12]. This sol–gel procedure is carried out at 80°C without co-solvent, in water solution and 
applying NaOH as a catalyst. The relative molar composition of the reaction mixture was: 1 
TEOS:0.12C16TMABr:0.31 NaOH:1190H2O. The formed gel was aged at 80°C for 2 h, then 
washed with distilled water until neutral pH, and dried at ambient. Template removal of 
MCM-41 materials was carried out in air up to 550°C with 1°C/min rate for 5 h. 
 
2.2.  Synthesis of nanosized KIL-2 material 
 
Mesoporous disordered silicate KIL-2  [13] was prepared by two-step synthesis in molar 
ratio of 1 TEOS:0.5 TEA:0.1 TEAOH: 11H2O. In the first step tetraorthosilicate (TEOS 98%, 
Acros) and triethanolamine (TEA 99%, Fluka) were stirred for 30 min. Then demineralized 
water was added to the above mixture, followed by the addition of tetraethyammonium 
hydroxide (TEAOH 20%, Acros). The solution was mixed with a magnetic stirrer to obtain a 
homogeneous gel. The final gel was aged overnight at room temperature and then dried in an 
oven at 50°C for 24 h. In the second step the gel was solvothermally treated in ethanol in a 
Teflon-lined stainless autoclave at 150°C for 48 h. Template was removed by calcination at 
500°C for 10 h in air flow. 
 
2.3.  Synthesis of nanosized BEA zeolite 
 
Zeolite beta nanoparticles were synthesized according to Ref.  [14]. In brief, the synthesis 
procedure includes the preparation of a precursor mixture with the following molar 
composition: 25.00 SiO2:0.25 Al2O3:9.0 R:0.35 Na2O:295.0H2O, where R is the organic 
templating agent tetramethylammonium (TEA) (Sigma, 20% TEAOH in water). The silica 
source was derived from a colloidal silica suspension Bindzil 30/360 (Eka Nobel, Sweden) 
containing 31.1 wt% SiO2 and 0.6 wt% Na2O. The suspension was freeze-dried to powder. 
The aluminum source was aluminum isopropylate (Sigma). The obtained initial mixture was a 
clear homogeneous solution, which was subjected to hydrothermal treatment at 100°C for 9 
days. The crystalline nanoparticles were purified by three times centrifugation at 20,000 rpm 
for 1 h, followed by redispersion in distilled water using an ultrasonic bath to obtain a 
colloidal sol with a pH of about 9.5. The sample in its H-form, H-BEA, is used for further 
resveratrol loading and is designated as R/BEA. 
 
 
 
 
2.4.  Characterization 
 
X-ray patterns were recorded by Philips PW 1810/3710 diffractometer with Bregg-
Brentano parafocusing geometry applying monochromatized Cu Kα (λ=0.15418 nm) 
radiation (40 kV,35 mA) and proportional counter. 
Nitrogen physisorption measurements were carried out at -196 °C using Quantachrome 
Autosorb 1C Gas Sorption Instrument. The BET surface area, the mean pore diameter, and 
the total volume of the samples was calculated and presented in Tables 1 and 2. The pore-size 
distributions were calculated from the desorption branch of the isotherms with the BJH 
method. Samples were pre-treated at 80°C before measurements. 
Thermogravimetric measurements (TG) were performed with a Setaram TG92 micro 
balance with a heating rate of 5°C/min in air flow. 
Attenuated total reflection infrared (ATR-FTIR) spectra were recorded by means of a 
Varian Scimitar 2000 FT-IR spectrometer equipped with a MCT (mercury-cadmium-tellur) 
detector and a single reflection ATR unit (SPECAC “Golden Gate”) with diamond ATR 
element. In general, 128 scans and 4 cm
_1
 resolution was applied. For all spectra ATR-
correction was performed (Varian ResPro 4.0 software). 
 
2.5. Resveratrol loading and in-vitro release measurements 
 
The powdered samples were loaded with resveratrol by two different methods: deposition 
by ethanol solution and by solid-state method. Ethanol was chosen as a solvent for drug 
loading because of high solubility of (R) in it. Deposition of resveratrol in solution was 
carried out by soaking the silica carriers, under continuous magnetic stirring for 24 h at 37°C 
in ethanolic solution of resveratrol. In practice 100 mg of resveratrol was dissolved in 5 ml of 
abs. ethanol and 100 mg of the carrier dried at 120°C was put into this solution. Than 20 ml 
of water was added to the solution and the ethanol was evaporated, the resveratrol loaded 
samples were recovered by centrifugation and dried for 24 h at 40°C. These preparations are 
designated as R/MCM-41(S), R/BEA(S) and R/KIL-2)(S). 
For the solid state method, 1:1 weight ratio of resveratrol to mesoporous carrier was used. 
Resveratrol was mixed with the carriers at room temperature by high energy milling in a 
DDR-GM 9458 type vibrational ball mill mixer for 3 min. The as-prepared samples are 
designated as R/MCM-41(SS), R/BEA(SS) and R/KIL-2) (SS). 
In-vitro drug release experiments were performed in phosphate buffer (pH=.4) at 37°C, 
under stirring at a rate of 100 min
_1
. At appropriate time intervals, 3 ml samples were 
withdrawn and analyzed with UV–vis spectroscopy at a wavelength of 306 nm. 
 
 
 
 
 
3.  Results and discussion 
 
3.1.  Material characterization 
 
The parent silica nanomaterials as well as their resveratrol-loaded formulations were 
characterized before and after resveratrol deposition using several techniques. 
The low-angle powder XRD patterns of KIL-2 and MCM-41 indicate that KIL-2 has a 
disordered mesoporous structure, whereas MCM-41 shows an ordered 2D hexagonal (p6mm) 
pore arrangement ( Fig. 1). The pattern of calcined nanobeta material in its H-form ( Fig. 1) 
show the typical diffraction peaks of BEA-type topology with the most intensive reflections at 
7.6 and 22.41 2θ° [15]. 
In  Fig. 1 A the XRD pattern of grinded R is compared to that of commercial form of the 
drug. The observed intensity decrease proves that treatment in the vibrational mixer leads to 
substantial amorphization of the antioxidant, being one of the objectives of solid-state 
preparation method. The intensity of the reflections of the grinded non-loaded resveratrol is 
58% of the pure one. Presence of crystalline resveratrol phase is registered on all loaded 
samples regardless of the method of drug loading. The most intensive XRD lines of the drug 
at 2θ°=16.4, 19, 22.3, 23.6, and 28.3 are clearly visible for the solid-state ( Fig. 1A) or 
solution-loaded ( Fig. 1B) preparations. This is an evidence that resveratrol is not only 
introduced in the pore channels, but can be found on the outer surface of the small 
nanoparticles or in the voids among the particles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. XRD patterns of resveratrol, zeolite BEA and resveratrol loaded systems prepared by 
solid-state method (A)and in solution(B). 
 
 
 
 
Table 1 
Textural and physico-chemical properties of the parent KIL-2 and MCM-41 mesoporous 
silica materials and their resveratrol-loaded formulations. 
Samples 
BET 
(m
2
/g) 
Pore diameter 
(nm) 
Pore volume 
(cm
3
/g) 
Loaded resveratrol 
(wt%) 
*
 
MCM-41 1175 2.7 0.97 – 
R/MCM-41(S) 320 2.5 0.26 39.8 
R/MCM-41(SS) 306 2.5 0.27 46.6 
KIL-2 664 15.2 1.28 – 
R/KIL-2(S) 320 9.8 0.72 35.8 
R/KIL-2(SS) 232 10 0.52 48.3 
* Determined by TGA by heating from 180°C to 600°C. 
 
Table 2 
Textural and physico-chemical properties of the parent BEA zeolite and its resveratrol-loaded 
formulations. 
Samples 
BET 
(m
2
/g) 
Total pore 
volume 
(cm
3
/g) 
Mesopore 
volume 
(cm
3
/g) 
Micropore 
volume 
(cm
3
/g) 
Loaded 
resveratrol 
(wt%) 
*
 
BEA 761 0.46 0.34 0.12 – 
R/BEA(S) 34 – n.d. – 48.4 
R/BEA(SS) 18 0.04 n.d. – 49.2 
* Determined by TGA by heating from 180°C to 600°C. 
 
 
According to SEM analysis (not shown), the size of the Beta zeolite crystallites is about 40–
50 nm. Images show that the particles stick together to 100–150 nm agglomerates and meso-
pores are formed among them. 
The particle size of the pure resveratrol and the resveratrol loaded samples was calculated 
according to the Sherrer equation and it is 35 nm. Resveratrol loading resulted in higher 
intensity decreases than the expected 50% (32% for R/MCM-41(SS), 40% for R/BEA(SS) 
and 37% for R/KIL-2(SS)). If we compare the intensity of resveratrol loaded by solution 
method to pure resveratrol we can find about 10% resveratrol. Comparing these data with the 
loaded amount determined by TG analysis we can conclude that a significant part of 
resveratrol is in amorphous form, not detectable by XRPD. 
Nitrogen adsorption and desorption isotherms of the parent, and resveratrol loaded MCM-
41, Beta, and KIL-2 samples are presented in  Fig. 2. The calculated textural parameters of 
MCM-41 and KIL-2 supports are summarized in  Table 1, and for BEA in  Table 2. The 
isotherms of MCM-41 samples are reversible and do not show any hysteresis loop ( Fig. 2A). 
They exhibit a sharp increase at a relative pressure between p/p0=0.2–0.4, which is associated 
with capillary condensation of nitrogen in the meso-pores and also indicates а narrow pore  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. N2 adsorption–desorption isotherms of the parent and the resveratrol-loaded MCM-41 
(A), KIL-2 (B) and zeolite BEA (C) prepared by solid-state (SS) method and in solution (S). 
 
size distribution. In isotherm of KIL-2 ( Fig. 2B), the hysteresis loop appears on the parent 
and the loaded materials at much higher relative pressure, which is an indication for the 
presence of bigger mesopores and high textural mesoporosity (see also Table 1). A sharp 
increase, typical for the micropore filling in zeolites at low relative pressures can be observed 
on the parent nano BEA sample. Then, at higher pressures, a hysteresis loop indicating intra-
particle mesoporosity among the agglomerated zeolite nanoparticles appears ( Fig. 2C). 
The textural parameters after R deposition alter significantly. The observed decrease in the 
surface area and pore volume is indicative for partial pore filling in the case of MCM-41 and 
KIL-2 after the solid-state loading of the drug. The change of I. type isotherm for BEA zeolite 
support is an indication for micropore filling or rather plugging. The microporosity of this 
material with much narrower channel system actually disappears and the total pore volume is 
strongly reduced ( Table 2). For both mesoporous supports loaded with R in ethanol solution, 
also partial pore filling is observed. 
ATR FT-IR method was used to investigate the interaction between resveratrol molecule 
and the nanoporous carriers after its deposition ( Fig. 3). The FT-IR spectrum of R shows 
three characteristic strong bands at 1606, 1585 and 1384 cm
_1
, belonging to double bond C─C 
stretchings of aromatic and olefinic groups, and of ring C─C stretching, 
 
  
 
 
 
 
 
 
 
 
 
 
Fig. 3. ATR FT-IR spectra of resveratrol, and the resveratrol-loaded silica samples prepared 
by solid-state method (A) and in solution (B). 
 
respectively. The bands at 1511, 1443 and 1324 cm
_1
 can be assigned to in plan and out of 
plane C─H bending, respectively [16]. After encapsulation into silica/zeolite framework, a 
slight blueshift of the resveratrol IR bands corresponding to vinylidene group and a decrease 
in intensity of the vinylidene C─H in plane bend (1324 cm_1) can be observed. These spectral 
features due to perturbation at vinylidene dipole moments suggest an interaction of resveratrol 
C═C with the silica/zeolite framework. The most pronounced changes are witnessed in case 
of BEA zeolite (solid-state preparation; shift of 1384 to 1391 cm
_1
 of C─C ring stretching) 
indicate a nanoconfinement of resveratrol in the micropores/mesopores of BEA. For all cases, 
the out of plane C─H bending of RCH=CHR (965 cm_1, not shown), diagnostic for trans-
configuration around the di-substituted double bond  [17], remains unchanged, indicating that 
the trans-configuration is preserved during encapsulation. 
 
3.2.  Resveratrol loading and in vitro release 
 
The adsorbed amount of Rl was evaluated by thermogravimetric analysis (TGA) 
considering the weight loss at heating the resveratrol-loaded preparations. At temperatures up 
to 180°C the formulations lose the physisorbed water ( Fig. 4). Above this temperature, the 
onset of short temperature interval of melting of the supported substance follows, and then 
fast drug decomposition occurs. The value for the R loading is listed in  Tables 1 and 2. It is 
calculated from the TGA data by subtracting the weight loss due to water released from room 
temperature to 180°C, from the total weight loss at 600°C. With the exception of the 
mesoporous silicates loaded by ethanol solution, almost complete retention of the deposited 
compound, corresponding to the envisaged 1:1 resveratrol-carrier weight ratio 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Fig. 4. TG profiles of resveratrol-loaded MCM-41 (A), BEA (B) and KIL-2 (C) in solid-state 
(SS) and in solution (S). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Release profiles of unsupported resveratrol, and the resveratrol-loaded MCM-41 (A), 
KIL-2 (B) and BEA (C) drug delivery systems prepared in solid state and in solution. 
 
is registered for the tree studied carriers ( Tables 1 and 2). This result points to the high 
effectiveness of the solid-state procedure for preparation of drug delivery systems. As it was 
expected and the TGA determinations showed, almost the whole amount of added sub-stance 
has remained on the carrier and evolved upon heating up to 600°C. The lower adsorption 
capacity for both R/MCM-41(S) and R/ KIL-2(S) preparations in comparison to the BEA 
zeolite can be explained by the difference in their pore size distribution. The much larger size 
of the mesoporous channels and, respectively, their higher pore volume, suggest more facile 
diffusion of resveratrol out of the channel system, when the loading is carried out in solution. 
 
Resveratrol release was carried out in phosphate buffer at pH = 7.4 and the kinetics of its 
evolution were followed by UV–vis spectroscopy at a wavelength of 306 nm, the 
characteristic signal of the bioactive trans-resveratrol form. The data showed only this signal 
in the samples taken from the released solution. The release experiments were repeated 3 
times with a period of one week between them and only trans-resveratrol was detected. This 
result is an indication that the loading on the chosen nanoporous carriers prevents the 
transformation of the supported bioactive trans-form to the less active cis-form. Thus, 
deposition of R on powdered silica-based carriers with mesoporous texture resulted in its 
stabilization and enhanced solubility. 
The release profiles of the loaded supports are presented in Fig. 5. Total release in about 
three hours was achieved for all resveratrol-loaded samples regardless of the preparation 
method. On the contrary, the free resveratrol and even the resveratrol treated by milling but 
not loaded on the carriers dissolves more slowly compared to that loaded in nanoporous 
systems. It indicates that the selected carriers and loading procedures substantially facilitate 
its dissolution. For the KIL-2 support ( Fig. 5B) almost similar release profiles are observed 
for both preparation methods. This parity can be explained by the presence of much larger 
mesopores, vis. the empty voids with the highest adsorption volume ( Table 1), formed among 
the nanoparticles of the KIL-2 carrier. This specific pore texture presumes equivalent location 
and surrounding of the supported substance and analogous adsorption characteristics. 
In the case of MCM-41 ( Fig. 5A) and the zeolite BEA ( Fig. 5C), the solid state method of 
loading ensures faster release compared to the analogue formulations prepared in ethanol 
solution. The presence of multiple pore system (internal and external mesoporosity in MCM-
41, and a simultaneous presence of micro- and mesopores in nanosized zeolite) presumes 
selective access of resveratrol to the pore system of the supports. This can result in diversity 
in the release kinetics depending on the method used for loading. The solid-state deposition 
occurs, most probably, on the outer surface of both supports and ensures faster and close 
release kinetics. The presence of narrower pore channels in the zeolite carrier is the reason for 
the lower rate of R delivery from it, compared to MCM-41, when the drug is loaded by the 
liquid deposition method. Resveratrol amorphization during the grinding procedure upon dry 
mixing also contributes to the easier release when the substance is loaded in solid-state. 
 
4.  Conclusions 
 
Loading of resveratrol on nanoporous MCM-41, KIL-2 silicas, and on nanosized BEA 
zeolite by two different methods (in solid-state and from ethanol solution) resulted in similar 
high loading capacity of the antioxidant. Considering the release profiles, all preparations 
showed better resveratrol solubility compared to the free resveratrol, regardless of the support 
structure and the method of loading. In vitro release process at pH=7.4 showed faster 
resveratrol delivery from MCM-41 and BEA carriers pre-pared by the solid state method in 
comparison to that in ethanol solution. Resveratrol release from both KIL-2 preparations was 
equally fast independently of the loading method. This effect can be associated with the 
different pore texture of the carriers. The applied solid-state procedure of preparation appears 
very effective for loading of the medical compound. It ensures preservation of the whole 
loaded drug amount as well as improves significantly the solubility of the loaded substance 
due to amorphization upon grinding. Deposition into the powdered mesoporous supports 
stabilizes the bioactive trans-resveratrol form. 
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